News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Conference News HFSA 2023 STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization L.A. McKeown October 18, 2023
News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
News Daily News Vast Majority of HFrEF Patients Eligible for Vericiguat L.A. McKeown February 08, 2023
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials Caitlin E. Cox December 11, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Daily News Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most Yael L. Maxwell November 07, 2019
News Daily News Nighttime Hypertension Drug Dosing May Reduce Risk of CVD L.A. McKeown October 23, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Conference News ESC 2019 Young MI Patients’ Ischemic Risk Extends at Least Two Decades Caitlin E. Cox September 06, 2019
News Daily News Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD L.A. McKeown April 03, 2019
News Conference News ESC 2018 Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm Todd Neale August 27, 2018
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete? Michael O'Riordan June 05, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients Michael O'Riordan January 17, 2017